CoChat

Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer’s disease pathology in mouse models

Manchanda, Shaffi, Galan-Acosta, Lorena, Abelein, Axel, Tambaro, Simone, Chen, Gefei, Nilsson, Per, Johansson, Jan · 2023 · Molecular Therapy
Cited by 38

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2022.08.010

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 32

  1. Benson, 2018, Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee, Amyloid., 25, 215, 10.1080/13506129.2018.1549825 · DOI · Paper page
  2. Kim, 2009, Bridging physiology and pathology in AD, Cell, 137, 997, 10.1016/j.cell.2009.05.042 · DOI
  3. Hardy, 1992, Alzheimer's disease: the amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 · DOI · Paper page
  4. Aschenbrenner, 2021, Controversial approval of new drug to treat alzheimer's disease, Am. J. Nurs., 121, 22
  5. Balchin, 2020, Recent advances in understanding catalysis of protein folding by molecular chaperones, FEBS Lett., 594, 2770, 10.1002/1873-3468.13844 · DOI · Paper page
  6. Kampinga, 2016, Heat shock proteins as potential targets for protective strategies in neurodegeneration, Lancet Neurol., 15, 748, 10.1016/S1474-4422(16)00099-5 · DOI · Paper page
  7. Sánchez-Pulido, 2002, BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer, Trends Biochem. Sci., 27, 329, 10.1016/S0968-0004(02)02134-5 · DOI · Paper page
  8. Hedlund, 2009, BRICHOS - a superfamily of multidomain proteins with diverse functions, BMC Res. Notes, 2, 180, 10.1186/1756-0500-2-180 · DOI
  9. Nerelius, 2008, Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C, Biochem. J., 416, 201, 10.1042/BJ20080981 · DOI
  10. Willander, 2012, High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C, Proc. Natl. Acad. Sci. USA, 109, 2325, 10.1073/pnas.1114740109 · DOI
  11. Buxbaum, 2017, Transthyretin and BRICHOS: the paradox of amyloidogenic proteins with anti-amyloidogenic activity for Aβ in the central nervous system, Front. Neurosci., 11, 119, 10.3389/fnins.2017.00119 · DOI
  12. Kurudenkandy, 2014, Amyloid-beta-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation, J. Neurosci., 34, 11416, 10.1523/JNEUROSCI.1195-14.2014 · DOI · Paper page
  13. Nerelius, 2009, Anti-amyloid activity of the C-terminal domain of proSP-C against amyloid beta-peptide and medin, Biochemistry, 48, 3778, 10.1021/bi900135c · DOI
  14. Poska, 2016, Dementia related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Abeta42 toxicity in Drosophila, Biochem. J., 473, 3683, 10.1042/BCJ20160277 · DOI
  15. Hermansson, 2014, The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster, Dis. Model. Mech., 7, 659
  16. Arosio, 2016, Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation, Nat. Commun., 7, 10948, 10.1038/ncomms10948 · DOI · Paper page
  17. Cohen, 2015, A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers, Nat. Struct. Mol. Biol., 22, 207, 10.1038/nsmb.2971 · DOI · Paper page
  18. Leppert, 2021, Smallest secondary nucleation competent abeta aggregates probed by an ATP-independent molecular chaperone domain, Biochemistry, 60, 678, 10.1021/acs.biochem.1c00003 · DOI
  19. Andrade-Talavera, 2021, Bri2 BRICHOS chaperone rescues impaired fast-spiking interneuron behavior and neuronal network dynamics in an AD mouse model in vitro, Neurobiol. Dis., 159, 105514, 10.1016/j.nbd.2021.105514 · DOI
  20. Galan-Acosta, 2020, Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons, Mol. Cell. Neurosci., 105, 103498, 10.1016/j.mcn.2020.103498 · DOI
  21. Tambaro, 2019, Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice, J. Biol. Chem., 294, 2606, 10.1074/jbc.RA118.004538 · DOI
  22. Chen, 2017, Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state, Nat. Commun., 8, 2081, 10.1038/s41467-017-02056-4 · DOI · Paper page
  23. Chen, 2020, Augmentation of Bri2 molecular chaperone activity against amyloid-beta reduces neurotoxicity in mouse hippocampus in vitro, Commun. Biol., 3, 32, 10.1038/s42003-020-0757-z · DOI · Paper page
  24. Shah, 2018, Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP(NL-F/NL-F) knock-in mice, Sci. Rep., 8, 6264, 10.1038/s41598-018-24657-9 · DOI · Paper page
  25. Abelein, 2020, High-yield production of amyloid-beta peptide enabled by a customized spider silk domain, Sci. Rep., 10, 235, 10.1038/s41598-019-57143-x · DOI · Paper page
  26. Olsen, 2018, Astroglial responses to amyloid-beta progression in a mouse model of alzheimer's disease, Mol. Imaging Biol., 20, 605, 10.1007/s11307-017-1153-z · DOI
  27. Linse, 2020, Kinetic fingerprints differentiate the mechanisms of action of anti-Abeta antibodies, Nat. Struct. Mol. Biol., 27, 1125, 10.1038/s41594-020-0505-6 · DOI · Paper page
  28. Ribary, 1991, Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans, Proc. Natl. Acad. Sci. USA, 88, 11037, 10.1073/pnas.88.24.11037 · DOI · Paper page
  29. Arroyo-García, 2021, Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App(NL-G-F) mouse model of Alzheimer's disease, Mol. Psychiatry, 26, 5557, 10.1038/s41380-021-01257-0 · DOI · Paper page
  30. Kronqvist, 2017, Efficient protein production inspired by how spiders make silk, Nat. Commun., 8, 15504, 10.1038/ncomms15504 · DOI
  31. Zhong, 2022, Amyloid fibril formation of Arctic amyloid-β 1–42 peptide is efficiently inhibited by the BRICHOS domain, ACS Chem. Biol., 17, 2201, 10.1021/acschembio.2c00344 · DOI
  32. Bates, 2015, Fitting linear mixed-effects models using lme4, J. Stat. Softw., 67, 1

Cited by

See all 38

Metadata

Authors
Manchanda, S., Galan-Acosta, L., Abelein, A., Tambaro, S., Chen, G., Nilsson, P., & Johansson, J.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2023-02
Volume
31
Issue
2
Pages
487-502
ISSN
1525-0016
Cited by
38
References
20
Language
en
Licence
Funders
  • Svenska Sällskapet för Medicinsk Forskning
  • Alzheimerfonden
  • Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
  • Torsten Söderbergs Stiftelse
  • Gun och Bertil Stohnes Stiftelse
  • Vetenskapsrådet (2020-02434, 2016-01967)
  • Hjärnfonden
  • Karolinska Institutet
  • Bertil Hållstens Forskningsstiftelse
  • Center for Innovative Medicine
  • Stiftelsen för Gamla Tjänarinnor
  • Petrus och Augusta Hedlunds Stiftelse
  • Magnus Bergvalls Stiftelse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer’s disease pathology in mouse models. https://app.cochat.ai/papers/10.1016/j.ymthe.2022.08.010
The paper
Manchanda, S., Galan-Acosta, L., Abelein, A., Tambaro, S., Chen, G., Nilsson, P., & Johansson, J. (2023). Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer’s disease pathology in mouse models. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2022.08.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.